A Triterpenoid‐Enriched GLE70 Fraction From Ganoderma lingzhi Ameliorates Alcoholic Liver Disease via Multi‐Target Regulation

Documenti analoghi

• Ellagic Acid Modulates Necroptosis, Autophagy, Inflammations, and Stress to Ameliorate Nonalcoholic Liver Fatty Disease in a Rat Model
  di: Zhuoheng Li, et al.
  Pubblicazione: (2025)
• Research Progress in the Application of Lactic Acid Bacteria in Alcoholic Liver Disease
  di: Longxuan Huo, et al.
  Pubblicazione: (2026)
• Integrative Network Pharmacology, Molecular Docking, and In Vitro Insights Into the Mechanism of Finger Citron for Non‐Alcoholic Fatty Liver Disease
  di: Qingpeng Li, et al.
  Pubblicazione: (2026)
• Quinoa Improves Non‐Alcoholic Fatty Liver Disease by Regulating the Ras‐ PLD Pathway to Activate Autophagy
  di: Yuelin Zhang, et al.
  Pubblicazione: (2025)
• Molecular Mechanism of Dihydroquercetin in Ameliorating Metabolic Dysfunction–Associated Steatotic Liver Disease: Insights Into the HIF ‐1α/ VEGF Pathway
  di: Xinyue Zhang, et al.
  Pubblicazione: (2026)